Cocrystal Pharma Inc

NASDAQ:COCP   3:59:11 PM EDT
0.95
-0.02 (-2.14%)
Earnings Announcements

Cocrystal Pharma Reports 2020 Financial Results, Provides Business Update Including Antiviral Program Milestones

Published: 03/17/2021 13:12 GMT
Cocrystal Pharma Inc (COCP) - Cocrystal Pharma Reports 2020 Financial Results, Provides Business Update Including Antiviral Program Milestones.
Cocrystal Pharma Inc - Reported $33.1 Million in Cash and Cash Equivalents As of December 31, 2020, Compared With $7.4 Million As of December 31, 2019.
Revenue is expected to be $0.28 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0.28 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.